1. Home
  2. AX vs KRYS Comparison

AX vs KRYS Comparison

Compare AX & KRYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AX
  • KRYS
  • Stock Information
  • Founded
  • AX 1999
  • KRYS 2015
  • Country
  • AX United States
  • KRYS United States
  • Employees
  • AX N/A
  • KRYS N/A
  • Industry
  • AX Savings Institutions
  • KRYS Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • AX Finance
  • KRYS Health Care
  • Exchange
  • AX Nasdaq
  • KRYS Nasdaq
  • Market Cap
  • AX 5.2B
  • KRYS 4.3B
  • IPO Year
  • AX 2005
  • KRYS 2017
  • Fundamental
  • Price
  • AX $89.99
  • KRYS $149.00
  • Analyst Decision
  • AX Strong Buy
  • KRYS Strong Buy
  • Analyst Count
  • AX 7
  • KRYS 10
  • Target Price
  • AX $90.43
  • KRYS $204.90
  • AVG Volume (30 Days)
  • AX 310.3K
  • KRYS 294.7K
  • Earning Date
  • AX 10-29-2025
  • KRYS 08-04-2025
  • Dividend Yield
  • AX N/A
  • KRYS N/A
  • EPS Growth
  • AX N/A
  • KRYS 36.22
  • EPS
  • AX 7.43
  • KRYS 4.91
  • Revenue
  • AX $1,203,093,000.00
  • KRYS $359,205,000.00
  • Revenue This Year
  • AX $12.79
  • KRYS $34.33
  • Revenue Next Year
  • AX $7.59
  • KRYS $47.84
  • P/E Ratio
  • AX $12.12
  • KRYS $30.30
  • Revenue Growth
  • AX 13.59
  • KRYS 116.08
  • 52 Week Low
  • AX $54.46
  • KRYS $122.80
  • 52 Week High
  • AX $92.99
  • KRYS $207.84
  • Technical
  • Relative Strength Index (RSI)
  • AX 58.78
  • KRYS 53.61
  • Support Level
  • AX $89.71
  • KRYS $143.09
  • Resistance Level
  • AX $92.99
  • KRYS $151.86
  • Average True Range (ATR)
  • AX 1.65
  • KRYS 4.38
  • MACD
  • AX 0.08
  • KRYS 0.31
  • Stochastic Oscillator
  • AX 59.62
  • KRYS 68.10

About AX Axos Financial Inc.

Axos Financial Inc is a bank holding company that operates through its bank subsidiary, BofI Federal Bank, a nationwide bank that provides financing for single and multifamily residential properties, small to medium-size businesses in certain sectors, and selected specialty finance receivables. Its operating segments are banking business segment and securities business segment. The bank distributed its products through a wide range of retail distribution channels, including only banking brands, affinity groups, and sales teams, among others. The majority of the bank's mortgage exposure is titled toward the state of California, particularly its southern region. Net interest income is a majority of the bank's revenue.

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.

Share on Social Networks: